Literature DB >> 30699860

The effectiveness of four empirically supported psychotherapies for primary care depression and anxiety: A systematic review and meta-analysis.

Anao Zhang1, Cynthia Franklin2, Shijie Jing3, Lindsay A Bornheimer4, Audrey Hang Hai2, Joseph A Himle5, Dexia Kong6, Qingying Ji7.   

Abstract

BACKGROUND: Depressive and anxiety disorders are highly prevalent and detrimental in primary care settings. However, there are gaps in the literature concerning effectiveness and generalizability of empirically supported interventions and treatment of both depression and anxiety in primary care settings. The aim of this review is to systematically assess and meta-analyze the effectiveness of brief empirically-supported psychotherapies for treating depression and/or anxiety in primary care.
METHODS: Seven electronic databases, five professional websites and manual search of reference lists were searched through April 2017 for randomized controlled trials (RCTs) of four psychotherapies treating primary care depression and anxiety: cognitive-behavior therapy (CBT), problem-solving therapy (PST), motivational interviewing (MI), and solution-focused brief therapy (SFBT).
RESULTS: From an initial pool of 1140 articles, 179 articles were eligible for full-text review and 65 articles were included for final analysis. Sixty-five articles containing 198 effect sizes reported an overall treatment effect size of d = 0.462, p < 0.001. Single-predictor meta-regression indicated that marital status, treatment modality (individual versus group), and treatment composition were significant moderators. Multiple-predictor meta-regression discovered treatment setting (inside versus outside primary care) significantly moderated treatment effect, b = -0.863, p = 0.039 after controlling for other intervention characteristics.
CONCLUSION: Treatment effects were found for CBT and PST, both for depressive and anxiety disorders. Interventions delivered outside primary care settings were more effective than those within, individual treatment had greater treatment effects compared to group treatment, and both technology-assisted and in-person treatments were found to be effective.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anxiety/anxiety disorders; Depression; Empirical supported treatments; Health services; Primary care

Mesh:

Year:  2018        PMID: 30699860     DOI: 10.1016/j.jad.2018.12.008

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  14 in total

1.  Reducing the prevalence of low-back pain by reducing the prevalence of psychological distress: Evidence from a natural experiment and implications for health care providers.

Authors:  Timothy T Brown; Christie Ahn; Haoyue Huang; Zaidat Ibrahim
Journal:  Health Serv Res       Date:  2020-10       Impact factor: 3.402

2.  Psychotherapy for Depression Across Different Age Groups: A Systematic Review and Meta-analysis.

Authors:  Pim Cuijpers; Eirini Karyotaki; Dikla Eckshtain; Mei Yi Ng; Katherine A Corteselli; Hisashi Noma; Soledad Quero; John R Weisz
Journal:  JAMA Psychiatry       Date:  2020-07-01       Impact factor: 21.596

3.  Effectiveness of Prompt Mental Health Care, the Norwegian Version of Improving Access to Psychological Therapies: A Randomized Controlled Trial.

Authors:  Marit Knapstad; Linn Vathne Lervik; Solbjørg Makalani Myrtveit Sæther; Leif Edvard Aarø; Otto Robert F Smith
Journal:  Psychother Psychosom       Date:  2019-12-03       Impact factor: 17.659

4.  Mental health specialist video consultations for patients with depression or anxiety disorders in primary care: protocol for a randomised controlled feasibility trial.

Authors:  Justus Tönnies; Mechthild Hartmann; Michel Wensing; Joachim Szecsenyi; Andrea Icks; Hans-Christoph Friederich; Markus W Haun
Journal:  BMJ Open       Date:  2019-09-04       Impact factor: 2.692

Review 5.  Psychological Treatment of Depression in Primary Care: Recent Developments.

Authors:  Pim Cuijpers; Soledad Quero; Christopher Dowrick; Bruce Arroll
Journal:  Curr Psychiatry Rep       Date:  2019-11-23       Impact factor: 5.285

6.  Superior knee self-efficacy and quality of life throughout the first year in patients who recover symmetrical muscle function after ACL reconstruction.

Authors:  Ramana Piussi; Susanne Beischer; Roland Thomeé; Eric Hamrin Senorski
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-09-25       Impact factor: 4.342

Review 7.  The effectiveness of Internet-delivered treatment for generalized anxiety disorder: An updated systematic review and meta-analysis.

Authors:  Nora Eilert; Angel Enrique; Rebecca Wogan; Olwyn Mooney; Ladislav Timulak; Derek Richards
Journal:  Depress Anxiety       Date:  2020-11-22       Impact factor: 6.505

8.  Mental Health Specialist Video Consultations Versus Treatment-as-Usual for Patients With Depression or Anxiety Disorders in Primary Care: Randomized Controlled Feasibility Trial.

Authors:  Justus Tönnies; Mechthild Hartmann; Michel Wensing; Joachim Szecsenyi; Frank Peters-Klimm; Regina Brinster; Dorothea Weber; Markus Vomhof; Andrea Icks; Hans-Christoph Friederich; Markus W Haun
Journal:  JMIR Ment Health       Date:  2021-03-12

9.  Mental health specialist video consultations versus treatment as usual in patients with depression or anxiety disorders in primary care: study protocol for an individually randomised superiority trial (the PROVIDE-C trial).

Authors:  Markus W Haun; Justus Tönnies; Regina Krisam; Dorothea Kronsteiner; Michel Wensing; Joachim Szecsenyi; Markus Vomhof; Andrea Icks; Beate Wild; Mechthild Hartmann; Hans-Christoph Friederich
Journal:  Trials       Date:  2021-05-05       Impact factor: 2.279

Review 10.  The Adoption of New Treatment Modalities by Health Professionals and the Relative Weight of Empirical Evidence in Favor of Virtual Reality Exposure Versus Mindfulness in the Treatment of Anxiety Disorders.

Authors:  Kevin Nolet; Giulia Corno; Stéphane Bouchard
Journal:  Front Hum Neurosci       Date:  2020-03-25       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.